AUPH logo

Aurinia Pharmaceuticals Inc. (AUPH) Retained Earnings

Annual Retained Earnings:

-$936.57M+$5.75M(+0.61%)
December 31, 2024

Summary

  • As of today, AUPH annual retained earnings is -$936.57 million, with the most recent change of +$5.75 million (+0.61%) on December 31, 2024.
  • During the last 3 years, AUPH annual retained earnings has fallen by -$180.45 million (-23.86%).
  • AUPH annual retained earnings is now -17003.49% below its all-time high of -$5.48 million, reached on November 30, 1998.

Performance

AUPH Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHbalance sheet metrics

Quarterly Retained Earnings:

-$860.16M+$31.55M(+3.54%)
September 30, 2025

Summary

  • As of today, AUPH quarterly retained earnings is -$860.16 million, with the most recent change of +$31.55 million (+3.54%) on September 30, 2025.
  • Over the past year, AUPH quarterly retained earnings has increased by +$77.84 million (+8.30%).
  • AUPH quarterly retained earnings is now -15533.06% below its all-time high of -$5.50 million, reached on February 28, 1999.

Performance

AUPH Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHbalance sheet metrics

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

AUPH Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+0.6%+8.3%
3Y3 Years-23.9%-2.6%
5Y5 Years-98.2%-38.8%

AUPH Retained Earnings Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-23.9%+0.6%-2.6%+9.8%
5Y5-Year-98.2%+0.6%-49.5%+9.8%
All-TimeAll-Time>-9999.0%+0.6%>-9999.0%+9.8%

AUPH Retained Earnings History

DateAnnualQuarterly
Sep 2025
-
-$860.16M(+3.5%)
Jun 2025
-
-$891.71M(+2.4%)
Mar 2025
-
-$913.23M(+2.5%)
Dec 2024
-$936.57M(+0.6%)
-$936.57M(+0.2%)
Sep 2024
-
-$938.00M(+1.5%)
Jun 2024
-
-$952.35M(+0.1%)
Mar 2024
-
-$953.07M(-1.1%)
Dec 2023
-$942.32M(-9.0%)
-$942.32M(-2.9%)
Sep 2023
-
-$915.45M(-1.5%)
Jun 2023
-
-$902.00M(-1.3%)
Mar 2023
-
-$890.51M(-3.0%)
Dec 2022
-$864.30M(-14.3%)
-$864.30M(-3.1%)
Sep 2022
-
-$838.26M(-1.1%)
Jun 2022
-
-$829.27M(-4.5%)
Mar 2022
-
-$793.75M(-5.0%)
Dec 2021
-$756.12M(-31.5%)
-$756.12M(-4.6%)
Sep 2021
-
-$722.80M(-7.5%)
Jun 2021
-
-$672.54M(-7.5%)
Mar 2021
-
-$625.53M(-8.8%)
Dec 2020
-$575.16M(-21.7%)
-$575.16M(+7.2%)
Sep 2020
-
-$619.93M(-5.8%)
Jun 2020
-
-$585.87M(-5.3%)
Mar 2020
-
-$556.34M(-3.1%)
Dec 2019
-$472.48M(-13.6%)
-$539.81M(-16.5%)
Sep 2019
-
-$463.33M(-4.3%)
Jun 2019
-
-$444.29M(-3.7%)
Mar 2019
-
-$428.39M(-3.0%)
Dec 2018
-$415.96M(-18.2%)
-$415.96M(-3.6%)
Sep 2018
-
-$401.37M(-4.8%)
Jun 2018
-
-$383.02M(-4.3%)
Mar 2018
-
-$367.32M(-4.4%)
Dec 2017
-$351.84M(-25.2%)
-$351.84M(-1.0%)
Sep 2017
-
-$348.51M(-3.9%)
Jun 2017
-
-$335.39M(-0.7%)
Mar 2017
-
-$332.99M(-18.5%)
Dec 2016
-$281.05M(-9.0%)
-$281.05M(-3.1%)
Sep 2016
-
-$272.71M(-2.8%)
Jun 2016
-
-$265.30M(-1.3%)
Mar 2016
-
-$262.02M(-1.7%)
Dec 2015
-$257.75M(-9.0%)
-$257.75M(-1.6%)
Sep 2015
-
-$253.69M(-2.1%)
Jun 2015
-
-$248.48M(-0.3%)
Mar 2015
-
-$247.75M(-4.8%)
Dec 2014
-$236.37M(-7.6%)
-$236.37M(-2.1%)
Sep 2014
-
-$231.45M(-1.1%)
Jun 2014
-
-$228.93M(-1.8%)
Mar 2014
-
-$224.92M(-2.4%)
Dec 2013
-$219.72M(-1.3%)
-$219.72M(-2.6%)
Sep 2013
-
-$214.22M(-3.8%)
Jun 2013
-
-$206.41M(+3.3%)
Mar 2013
-
-$213.35M(+1.6%)
DateAnnualQuarterly
Dec 2012
-$216.89M(-7.1%)
-$216.89M(-1.3%)
Sep 2012
-
-$214.21M(-4.5%)
Jun 2012
-
-$205.08M(+0.9%)
Mar 2012
-
-$206.84M(-2.1%)
Dec 2011
-$202.58M(+1.2%)
-$202.58M(-5.7%)
Sep 2011
-
-$191.68M(+8.4%)
Jun 2011
-
-$209.29M(+1.5%)
Mar 2011
-
-$212.50M(-3.6%)
Dec 2010
-$205.12M(-7.5%)
-$205.12M(-4.6%)
Sep 2010
-
-$196.14M(-4.4%)
Jun 2010
-
-$187.89M(+4.3%)
Mar 2010
-
-$196.32M(-2.9%)
Dec 2009
-$190.75M(-22.6%)
-$190.75M(-3.2%)
Sep 2009
-
-$184.87M(-9.2%)
Jun 2009
-
-$169.30M(-8.6%)
Mar 2009
-
-$155.90M(-0.2%)
Dec 2008
-$155.54M(+11.1%)
-$155.54M(+11.6%)
Sep 2008
-
-$176.04M(+2.6%)
Jun 2008
-
-$180.82M(-4.2%)
Mar 2008
-
-$173.50M(+0.8%)
Dec 2007
-$174.97M(-46.3%)
-$174.97M(-5.9%)
Sep 2007
-
-$165.27M(-12.1%)
Jun 2007
-
-$147.47M(-15.8%)
Mar 2007
-
-$127.38M(-6.7%)
Dec 2006
-$119.61M(-24.1%)
-$119.42M(-1.3%)
Sep 2006
-
-$117.84M(-5.4%)
Jun 2006
-
-$111.81M(-10.5%)
Mar 2006
-
-$101.15M(-4.4%)
Dec 2005
-$96.35M(-46.5%)
-$96.91M(-10.9%)
Sep 2005
-
-$87.42M(-12.5%)
Jun 2005
-
-$77.71M(-7.8%)
Mar 2005
-
-$72.10M(-10.0%)
Dec 2004
-$65.76M(-64.5%)
-$65.54M(-19.6%)
Sep 2004
-
-$54.82M(-21.8%)
Jun 2004
-
-$45.02M(-6.4%)
Mar 2004
-
-$42.30M(-6.2%)
Dec 2003
-$39.98M(-95.5%)
-$39.84M(-24.5%)
Sep 2003
-
-$32.01M(-16.6%)
Jun 2003
-
-$27.45M(-4.7%)
Mar 2003
-
-$26.21M(-27.7%)
Dec 2002
-$20.45M(-3.4%)
-$20.52M(-17.3%)
Sep 2002
-
-$17.50M(+16.4%)
Jun 2002
-
-$20.92M(+4.4%)
Mar 2002
-
-$21.88M(-215.9%)
Dec 2001
-$19.79M(-50.1%)
-
Dec 2000
-$13.18M(-91.3%)
-
Nov 1999
-$6.89M(-25.9%)
-$6.93M(-17.6%)
Aug 1999
-
-$5.89M(+2.5%)
May 1999
-
-$6.04M(-9.7%)
Feb 1999
-
-$5.50M
Nov 1998
-$5.48M
-

FAQ

  • What is Aurinia Pharmaceuticals Inc. annual retained earnings?
  • What is the all-time high annual retained earnings for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. annual retained earnings year-on-year change?
  • What is Aurinia Pharmaceuticals Inc. quarterly retained earnings?
  • What is the all-time high quarterly retained earnings for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. quarterly retained earnings year-on-year change?

What is Aurinia Pharmaceuticals Inc. annual retained earnings?

The current annual retained earnings of AUPH is -$936.57M

What is the all-time high annual retained earnings for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high annual retained earnings is -$5.48M

What is Aurinia Pharmaceuticals Inc. annual retained earnings year-on-year change?

Over the past year, AUPH annual retained earnings has changed by +$5.75M (+0.61%)

What is Aurinia Pharmaceuticals Inc. quarterly retained earnings?

The current quarterly retained earnings of AUPH is -$860.16M

What is the all-time high quarterly retained earnings for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high quarterly retained earnings is -$5.50M

What is Aurinia Pharmaceuticals Inc. quarterly retained earnings year-on-year change?

Over the past year, AUPH quarterly retained earnings has changed by +$77.84M (+8.30%)
On this page